[Skip to Content]
Access to paid content on this site is currently suspended due to excessive activity being detected from your IP address 54.146.141.60. Please contact the publisher to request reinstatement.
[Skip to Content Landing]
Article
January 1979

Pleural Fluid Lysozyme in Human Disease

Author Affiliations

From the Fourth Department of Medicine, Helsinki University Central Hospital, Helsinki, Finland (Drs Klockars, Pettersson, and Riska); Departments of Medicine and Chest Medicine, Mjölbolsta Hospital, Mjölbolsta, Finland (Dr Hellström); and Department of Chest Medicine, Uttrans Hospital, Uttran, Sweden (Dr Norhagen).

Arch Intern Med. 1979;139(1):73-77. doi:10.1001/archinte.1979.03630380051018
Abstract

Lysozyme content was measured in the plasma and pleural fluid of 110 patients with pleural effusions of various causes. The concentration of pleural fluid lysozyme was significantly higher (P <.001) in patients with tuberculous pleurisy than in those with primary pulmonary carcinoma, metastatic carcinoma of the lung, connective tissue disease, nonspecific pleurisy, or congestive heart failure. Tuberculous patients also had a significantly higher (P <.001) pleural fluid-to-plasma lysozyme ratio than did the other patients. Plasma lysozyme activity did not differ significantly among the various patient groups.

Lysozyme was identified immunohistochemically in epithelioid cell granulomas in tuberculosis, in activated macrophages in lymph nodes adjacent to tuberculous lesions, and in granulocytes in pleural empyema. No lysozyme was detected in neoplastic cells in pulmonary carcinoma.

The results show that the determination of pleural fluid lysozyme is a simple, fast method for obtaining corroborative information in the differential diagnosis of tuberculous pleurisy.

(Arch Intern Med 139:73-77, 1979)

×